Intellectual Property special counsel Christine Willgoos will speak at ACI's 7th Annual Biosimilars Summit, being held June 13-14, 2016, at the New York Marriott Downtown. She will take part in the panel discussion titled “Mapping Out the BPCIA Process: A Cheat Sheet on Navigating the Biosimilars Pathway” on the second day of the summit.
Kramer Levin is also a sponsor of the summit.